Quarterly report · Q2
9989.TEDINET S100PMIV
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥339.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥648.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥326.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥18.5bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥17.9bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥18.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥34.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.2bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥18.5bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥18.3bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥23.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥12.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥337.1bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥325.8bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥313.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥108.0bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥105.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥229.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥220.6bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥213.3bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥94.5bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥89.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥94.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥90.3bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥21.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥31.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥16.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥20.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥108.81 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.94 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥204.02 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥106.54 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.36 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥108.81 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥204.01 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥106.53 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 68.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥24.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥24.7bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥143.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥143.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥5m |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥220.0bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥195.3bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥24.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥363.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥339.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥24.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥18.5bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥22.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥22.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥134.1bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥134.1bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6m |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥215.5bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥192.6bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥22.9bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥349.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥326.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥22.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥17.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 480
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital surplus | Prior1YearInstant | 7430000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 7430000000 | JPY |
| Retained earnings | Prior1YearInstant | 215145000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 223658000000 | JPY |
| Treasury stock | Prior1YearInstant | -3939000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -3939000000 | JPY |
| Shareholders equity | Prior1YearInstant | 222567000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 231080000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 56000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 65000000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | -1940000000 | JPY |
| Revaluation reserve for land | CurrentQuarterInstant | -1940000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -120000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -113000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -2003000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | -1988000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 28000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 31000000 | JPY |
| Net assets | Prior1YearInstant | 220592000000 | JPY |
| Net assets | CurrentQuarterInstant | 229123000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 325768000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 337090000000 | JPY |
| Net sales | Prior1YTDDuration | 326754000000 | JPY |
| Net sales | CurrentYTDDuration | 339223000000 | JPY |
| Cost of sales | Prior1YTDDuration | 248394000000 | JPY |
| Cost of sales | CurrentYTDDuration | 257026000000 | JPY |
| Gross profit | Prior1YTDDuration | 78359000000 | JPY |
| Gross profit | CurrentYTDDuration | 82196000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 60431000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 63685000000 | JPY |
| Operating income | Prior1YTDDuration | 17928000000 | JPY |
| Operating income | CurrentYTDDuration | 18511000000 | JPY |
| Interest income noi | Prior1YTDDuration | 61000000 | JPY |
| Interest income noi | CurrentYTDDuration | 60000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 3000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 3000000 | JPY |
| Gain on donation of noncurrent assets noi | Prior1YTDDuration | 140000000 | JPY |
| Gain on donation of noncurrent assets noi | CurrentYTDDuration | 112000000 | JPY |
| Other noi | Prior1YTDDuration | 109000000 | JPY |
| Other noi | CurrentYTDDuration | 100000000 | JPY |
| Non operating income | Prior1YTDDuration | 316000000 | JPY |
| Non operating income | CurrentYTDDuration | 275000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 3000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 15000000 | JPY |
| Other noe | Prior1YTDDuration | 0 | JPY |
| Other noe | CurrentYTDDuration | 2000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 4000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 17000000 | JPY |
| Ordinary income | Prior1YTDDuration | 18240000000 | JPY |
| Ordinary income | CurrentYTDDuration | 18769000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |